These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24335843)

  • 21. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
    Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K; Ikarashi T
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of doxazosin enantiomers in rat plasma and investigation of their chiral inversion].
    Zhen YQ; Kong DZ; Li Q; Zhao J; Ren LM
    Yao Xue Xue Bao; 2013 Jun; 48(6):901-5. PubMed ID: 23984526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and pharmacodynamics of doxazosin compared with atenolol during long-term double-blind treatment.
    Faulkner JK; Himanen P; Karjalainen U; Saraste M
    Eur J Clin Pharmacol; 1987; 31(6):685-93. PubMed ID: 2951261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of doxazosin mesilate on cerebral blood flow in patients with hypertension and chronic cerebral infarction.
    Usuda K; Katayama Y
    J Nippon Med Sch; 2009 Jun; 76(3):148-53. PubMed ID: 19602821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats.
    Jeon BH; Kim CS; Park KS; Lee JW; Park JB; Kim KJ; Kim SH; Chang SJ; Nam KY
    Gen Pharmacol; 2000 Sep; 35(3):135-41. PubMed ID: 11744235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotensive effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs.
    Shibasaki K; Takizawa K; Uchida W; Takenaka T
    Jpn J Pharmacol; 1997 Feb; 73(2):113-24. PubMed ID: 9074945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
    Davis BR; Cutler JA; Furberg CD; Wright JT; Farber MA; Felicetta JV; Stokes JD;
    Ann Intern Med; 2002 Sep; 137(5 Part 1):313-20. PubMed ID: 12204014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxazosin suppresses the morning increase in blood pressure and sympathetic nervous activity in patients with essential hypertension.
    Kawano Y; Tochikubo O; Watanabe Y; Miyajima E; Ishii M
    Hypertens Res; 1997 Sep; 20(3):149-56. PubMed ID: 9328795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I; Stokke HP
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacological studies with doxazosin.
    Elliott HL; Meredith PA; Vincent J; Reid JL
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):27S-31S. PubMed ID: 2871854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
    Ozawa H; Matsubara T; Chen CS
    Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats.
    Perusquía M; Herrera N; Ferrer M; Stallone JN
    J Steroid Biochem Mol Biol; 2017 Mar; 167():106-114. PubMed ID: 27888135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta.
    Yono M; Foster HE; Shin D; Takahashi W; Pouresmail M; Latifpour J
    Life Sci; 2004 Oct; 75(21):2605-14. PubMed ID: 15363664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in blood pressure and heart rate in conscious rats with cervical lymphatic blockade.
    Zheng YH; Xia ZL; Chen LB; Zhao XM; Xia Q; Song XJ
    Chin J Physiol; 2008 Jun; 51(3):178-85. PubMed ID: 18935913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1989 Nov; 28(5):517-26. PubMed ID: 2531605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats.
    Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.